ARDT 📈 Ardent Health Partners - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock •
ARDT: Hospitals, Clinics, Healthcare, Rehabilitation, Surgery
Ardent Health Partners, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, Inc. is a subsidiary of EGI-AM Investments, L.L.C. Web URL: https://www.ardenthealth.com
Additional Sources for ARDT Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
ARDT Stock Overview
| Market Cap in USD | 2,591m |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| GiC Sub-Industry | Health Care Facilities |
| IPO / Inception | 2024-07-18 |
ARDT Stock Ratings
| Growth 5y | -5.54% |
| Fundamental | 36.0% |
| Dividend | - |
| Rel. Strength Industry | 94.7 |
| Analysts | 4.4/5 |
| Fair Price Momentum | 14.82 USD |
| Fair Price DCF | 17.55 USD |
ARDT Dividends
No Dividends PaidARDT Growth Ratios
| Growth Correlation 3m | -81.1% |
| Growth Correlation 12m | -19.3% |
| Growth Correlation 5y | -19.3% |
| CAGR 5y | -0.31% |
| CAGR/Mean DD 5y | -0.03 |
| Sharpe Ratio 12m | 0.03 |
| Alpha | -8.29 |
| Beta | 0.16 |
| Volatility | 48.21% |
| Current Volume | 487.2k |
| Average Volume 20d | 252.2k |
What is the price of ARDT stocks?
As of December 21, 2024, the stock is trading at USD 16.01 with a total of 487,200 shares traded.
Over the past week, the price has changed by -4.07%, over one month by -2.62%, over three months by -12.42% and over the past year by -0.31%.
As of December 21, 2024, the stock is trading at USD 16.01 with a total of 487,200 shares traded.
Over the past week, the price has changed by -4.07%, over one month by -2.62%, over three months by -12.42% and over the past year by -0.31%.
Is Ardent Health Partners a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Ardent Health Partners (NYSE:ARDT) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 36.04 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ARDT as of December 2024 is 14.82. This means that ARDT is currently overvalued and has a potential downside of -7.43%.
Partly, yes. Based on ValueRay Fundamental Analyses, Ardent Health Partners (NYSE:ARDT) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 36.04 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ARDT as of December 2024 is 14.82. This means that ARDT is currently overvalued and has a potential downside of -7.43%.
Is ARDT a buy, sell or hold?
Ardent Health Partners has received a consensus analysts rating of 4.40. Therefor, it is recommend to buy ARDT.
Ardent Health Partners has received a consensus analysts rating of 4.40. Therefor, it is recommend to buy ARDT.
- Strong Buy: 6
- Buy: 2
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecast for ARDT stock price target?
According to ValueRays Forecast Model, ARDT Ardent Health Partners will be worth about 16 in December 2025. The stock is currently trading at 16.01. This means that the stock has a potential upside of +0%.
According to ValueRays Forecast Model, ARDT Ardent Health Partners will be worth about 16 in December 2025. The stock is currently trading at 16.01. This means that the stock has a potential upside of +0%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 22.8 | 42.3% |
| Analysts Target Price | 22.8 | 42.3% |
| ValueRay Target Price | 16 | 0% |